APA (7th ed.) Citation

X, J., WZ, L., YH, G., G, W., WY, H., & F, C. (2025). Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab. European radiology, 35(8), 5135. https://doi.org/10.1007/s00330-025-11433-3

Chicago Style (17th ed.) Citation

X, Jin, Li WZ, Guo YH, Wu G, Huang WY, and Chen F. "Predicting Progression-free Survival Using Dynamic Contrast-enhanced Imaging-based Radiomics in Advanced Nasopharyngeal Carcinoma Patients Treated with Nimotuzumab." European Radiology 35, no. 8 (2025): 5135. https://doi.org/10.1007/s00330-025-11433-3.

MLA (9th ed.) Citation

X, Jin, et al. "Predicting Progression-free Survival Using Dynamic Contrast-enhanced Imaging-based Radiomics in Advanced Nasopharyngeal Carcinoma Patients Treated with Nimotuzumab." European Radiology, vol. 35, no. 8, 2025, p. 5135, https://doi.org/10.1007/s00330-025-11433-3.